The award recognizes startups and digital solutions that contribute to achieving the United Nations' 17 Sustainable Development Goals through the orientation of their company. Maria Sievert, Co-founder and CEO of Inveox says:
"Medtech startups like Inveox can make a significant contribution to improving the health of people around the world through digitalization and, in the future, artificial intelligence. Our team's goal is to pave the way for faster, more accurate, and more reliable cancer diagnoses by streamlining and automating the current pre-analytical process in the laboratory. With this goal, we help physicians, pathologists, and patients."
“Inveox is a perfect example of innovative process and quality improvements in medicine”
The second CEO and founder of the Medtech startups Dominik Sievert added:
"With the Inveox Pathology 4.0 solution, we are creating the laboratory of the future by bringing big data, AI, and machine learning into the lab. This can provide scientists with better research data, which can ultimately contribute to reducing or even eliminating oncological diseases. By enabling rapid and uncomplicated global exchange and validation of diagnoses thanks to digitalization, we are also contributing to a more equitable healthcare system overall."
Alexander Felsenberg, board member of WSA Germany, praises the winning company:
"For me, Inveox's software and hardware solution is a perfect example of innovative process and quality improvements in medicine that can address and improve people's suffering globally."
